STACEY LOPEZ: Open Payments
NPI 1134769292 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,701 in 80 payments from 18 companies in 2025. Trend: 2023 $3,742 · 2024 $4,571 · 2025 $2,701
Food & beverage: $2,614Education: $87
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $692 |
| ABBVIE INC. | 4 | $295 |
| UCB, Inc. | 7 | $250 |
| Arcutis Biotherapeutics, Inc. | 7 | $230 |
| Galderma Laboratories, L.P. | 8 | $188 |
| Organon LLC | 2 | $165 |
| PFIZER INC. | 5 | $162 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $149 |
| Amgen Inc. | 2 | $140 |
| Regeneron Healthcare Solutions, Inc. | 4 | $107 |
Products named: TREMFYA, Zoryve, Bimzelx, NEMLUVIO, SKYRIZI, CIBINQO, VTAMA, OTEZLA.
Industry payments across TX — which companies pay providers there.
